These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9506646)

  • 1. Adverse neurodevelopmental outcome after extracorporeal membrane oxygenation among neonates with bronchopulmonary dysplasia.
    Kornhauser MS; Baumgart S; Desai SA; Stanley CW; Culhane J; Cullen JA; Wiswell TE; Graziani LJ; Spitzer AR
    J Pediatr; 1998 Feb; 132(2):307-11. PubMed ID: 9506646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for bronchopulmonary dysplasia after extracorporeal membrane oxygenation.
    Kornhauser MS; Cullen JA; Baumgart S; McKee LJ; Gross GW; Spitzer AR
    Arch Pediatr Adolesc Med; 1994 Aug; 148(8):820-5. PubMed ID: 8044256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survivors of extracorporeal membrane oxygenation at 1 year of age: the relationship of primary diagnosis with health and neurodevelopmental sequelae.
    Bernbaum J; Schwartz IP; Gerdes M; D'Agostino JA; Coburn CE; Polin RA
    Pediatrics; 1995 Nov; 96(5 Pt 1):907-13. PubMed ID: 7478834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of infants with bronchopulmonary dysplasia who receive extracorporeal membrane oxygenation therapy.
    Hibbs A; Evans JR; Gerdes M; Hunter JV; Cullen JA
    J Pediatr Surg; 2001 Oct; 36(10):1479-84. PubMed ID: 11584392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary sequelae at six months following extracorporeal membrane oxygenation.
    Garg M; Kurzner SI; Bautista DB; Lew CD; Ramos AD; Platzker AC; Keens TG
    Chest; 1992 Apr; 101(4):1086-90. PubMed ID: 1555425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective, controlled study of developmental outcome in survivors of extracorporeal membrane oxygenation: the first 24 months.
    Wildin SR; Landry SH; Zwischenberger JB
    Pediatrics; 1994 Mar; 93(3):404-8. PubMed ID: 7509481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurodevelopmental outcome after neonatal extracorporeal membrane oxygenation.
    Robertson CM; Finer NN; Sauve RS; Whitfield MF; Belgaumkar TK; Synnes AR; Grace MG
    CMAJ; 1995 Jun; 152(12):1981-8. PubMed ID: 7540105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seizures as a predictor of long-term neurodevelopmental outcome in survivors of neonatal extracorporeal membrane oxygenation (ECMO).
    Parish AP; Bunyapen C; Cohen MJ; Garrison T; Bhatia J
    J Child Neurol; 2004 Dec; 19(12):930-4. PubMed ID: 15704865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying at risk infants following neonatal extracorporeal membrane oxygenation.
    Kumar P; Shankaran S; Bedard MP; Delaney-Black V
    J Perinatol; 1999; 19(5):367-72. PubMed ID: 10685259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The collaborative UK ECMO (Extracorporeal Membrane Oxygenation) trial: follow-up to 1 year of age.
    Pediatrics; 1998 Apr; 101(4):E1. PubMed ID: 9521968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of bronchopulmonary dysplasia on early intellectual development in preterm infants.
    Lin F; Dong H; Song Y; Zhang T; Qi J; Xiao X; Cai Y
    Pediatr Int; 2017 Jun; 59(6):691-697. PubMed ID: 28177185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An interdisciplinary bronchopulmonary dysplasia program is associated with improved neurodevelopmental outcomes and fewer rehospitalizations.
    Shepherd EG; Knupp AM; Welty SE; Susey KM; Gardner WP; Gest AL
    J Perinatol; 2012 Jan; 32(1):33-8. PubMed ID: 21546943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bronchopulmonary dysplasia and neurodevelopmental outcome in extremely preterm neonates.
    Trittmann JK; Nelin LD; Klebanoff MA
    Eur J Pediatr; 2013 Sep; 172(9):1173-80. PubMed ID: 23644648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chorioamnionitis at birth does not increase the risk of neurodevelopmental disability in premature infants with bronchopulmonary dysplasia.
    Bashir RA; Bhandari V; Vayalthrikkovil S; Rabi Y; Soraisham A; Tang S; Al Awad E; Lodha A
    Acta Paediatr; 2016 Nov; 105(11):e506-e512. PubMed ID: 27552089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infants with bronchopulmonary dysplasia. Growth pattern and neurologic and developmental outcome.
    Vohr BR; Bell EF; Oh W
    Am J Dis Child; 1982 May; 136(5):443-7. PubMed ID: 6177239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental outcomes of preterm infants with bronchopulmonary dysplasia-associated pulmonary hypertension at 18-24 months of corrected age.
    Choi EK; Shin SH; Kim EK; Kim HS
    BMC Pediatr; 2019 Jan; 19(1):26. PubMed ID: 30654786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia.
    Ehrenkranz RA; Walsh MC; Vohr BR; Jobe AH; Wright LL; Fanaroff AA; Wrage LA; Poole K;
    Pediatrics; 2005 Dec; 116(6):1353-60. PubMed ID: 16322158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of preterm infants with respiratory disease.
    Saigal S; O'Brodovich H
    Clin Perinatol; 1987 Sep; 14(3):635-50. PubMed ID: 2444378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health and developmental outcomes at 18 months in very preterm infants with bronchopulmonary dysplasia.
    Grégoire MC; Lefebvre F; Glorieux J
    Pediatrics; 1998 May; 101(5):856-60. PubMed ID: 9565414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental outcome in newborn infants treated for acute respiratory failure with extracorporeal membrane oxygenation: present experience.
    Khambekar K; Nichani S; Luyt DK; Peek G; Firmin RK; Field DJ; Pandya HC
    Arch Dis Child Fetal Neonatal Ed; 2006 Jan; 91(1):F21-5. PubMed ID: 16159956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.